Zobrazeno 1 - 6
of 6
pro vyhledávání: '"James M Bilakovics"'
Autor:
James R. Paterniti, James M. Bilakovics, Mccarthy James R, William R. Bensch, Joseph T. Brozinick, Brian A. Oldham, Garret J. Etgen, Kathleen M. Ogilvie, Sha Liu, Christopher John Rito, Carol L. Broderick, Anthony J. Shuker, Robert J. Ardecky, James S. Bean, Elizabeth A. Misener, John S. Tyhonas, Sharon L. Dana, William T. Johnson, Dawn A. Brooks, Raymond F. Kauffman, Chahrzad R. Montrose
Publikováno v:
Diabetes. 51:1083-1087
A novel nonthiazolidinedione dual peroxisome proliferator- activated receptor (PPAR)-α/γ agonist, LY465608, was designed to address the major metabolic disturbances of type 2 diabetes. LY465608 altered PPAR-responsive genes in liver and fat of db/d
Autor:
Richard A. Pittner, Nancy L. Andon, Soumitra S. Ghosh, Michael R. Hanley, James M Bilakovics, Carolyn Lowe, Steven W. Taylor
Publikováno v:
Journal of proteome research. 5(7)
A novel approach is presented for the simultaneous identification and relative quantification of secreted peptides, particularly those that have been historically difficult to analyze in a concerted manner. Peptides exceeding 60 residues with various
Autor:
Mark D. Leibowitz, Kay Klausing, Bernadette Pascual, Diane Jolley, Mary S. Urcan, Sha Liu, Danmei Li, James M. Bilakovics, Mark A. Lawson, Kathleen M. Ogilvie, Nancy I. Hein
Publikováno v:
Endocrinology. 143(8)
The retinoid X receptor (RXR) agonist bexarotene can cause clinically significant hypothyroidism in cutaneous T cell lymphoma patients. The mechanism by which the RXR agonist produces this effect is unclear. We have studied the impact of a selective
Autor:
Garret J, Etgen, Brian A, Oldham, William T, Johnson, Carol L, Broderick, Chahrzad R, Montrose, Joseph T, Brozinick, Elizabeth A, Misener, James S, Bean, William R, Bensch, Dawn A, Brooks, Anthony J, Shuker, Christopher J, Rito, James R, McCarthy, Robert J, Ardecky, John S, Tyhonas, Sharon L, Dana, James M, Bilakovics, James R, Paterniti, Kathleen M, Ogilvie, Sha, Liu, Raymond F, Kauffman
Publikováno v:
Diabetes. 51(4)
A novel nonthiazolidinedione dual peroxisome proliferator- activated receptor (PPAR)-alpha/gamma agonist, LY465608, was designed to address the major metabolic disturbances of type 2 diabetes. LY465608 altered PPAR-responsive genes in liver and fat o
Autor:
Raymond F. Kauffman, James R. Paterniti, Diane L. Crombie, Kathleen M. Ogilvie, Ranjan Mukherjee, Patricia A. Hoener, Sharon L. Dana, James M. Bilakovics
Publikováno v:
Metabolism: clinical and experimental. 50(8)
Fibrates and thiazolidinediones are used clinically to treat hypertriglyceridemia and hyperglycemia, respectively. Fibrates bind to the peroxisome proliferator-activated receptor (PPAR)-alpha, and thiazolidinediones are ligands of PPAR-gamma. These i
Autor:
Patricia A. Hoener, James R. Paterniti, Kay Klausing, Ranjan Mukherjee, Glenn Croston, Amy Faulkner, Dale E. Mais, James M. Bilakovics, Lily Jow
Publikováno v:
Molecular endocrinology (Baltimore, Md.). 14(9)
Peroxisome proliferator-activated receptor-gamma (PPARgamma) agonists such as the thiazolidinediones are insulin sensitizers used in the treatment of type 2 diabetes. These compounds induce adipogenesis in cell culture models and increase weight gain